Immune reconstitution syndrome and exacerbation of infections after pregnancy

Clinical Infectious Diseases

Volumn 45, Issue 9, 2007, Pages 1192-1199

  Singh, Nina ^a,b   Perfect, John R ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; FLUCONAZOLE; IMMUNOGLOBULIN;

AUTOIMMUNE DISEASE; COCCIDIOIDES IMMITIS; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE EXACERBATION; DISEASE MARKER; DRUG MEGADOSE; HEPATITIS B; HEPATITIS C; HEPATITIS VIRUS; HERPES; HERPES VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LEPROSY; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NERVE INJURY; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK FACTOR; SYMPTOM; TUBERCULOSIS;

AUTOIMMUNE DISEASES; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; POSTPARTUM PERIOD; PREGNANCY; PUERPERAL DISORDERS; PUERPERAL INFECTION; RISK FACTORS;

EID: 35348819904     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/522182     Document Type: Review

References (93)

1. Casadevall A, Pirofski LA. The damage-response framework of microbial pathogenesis. Nat Rev Microbiol 2003; 1:17-24.
2. Roilides E, Dignani MC, Anaissie EJ, et al. The role of immunoreconstitution in the management of refractory opportunistic fungal infections. Med Mycol 1998; 36:12-25.
3. Duncan M, Melsom R, Pearson J, et al. The association of pregnancy and leprosy: new cases, relapse of cured patients and deterioration in patients on treatment during pregnancy and lactation - results of a prospective study of 154 pregnancies in 147 Ethiopian women. Lepr Rev 1981; 52:245-62.
4. Beeson PB. Cryptococcic meningitis of nearly sixteen years' duration. Arch Intern Med 1952; 89:797-801.
5. Costeas PA, Koumouli A, Giantsiou-Kyriakou A, et al. Th2/Th3 cytokine genotypes are associated with pregnancy loss. Human Immunology 2004; 65:135-41.
6. Gaunt G, Ramin K. Immunological tolerance of the human fetus. Am J Perinatol 2001; 18:299-312.
7. Poole J, Claman HN. Immunology of pregnancy: implications for the mother. Clin Rev Allergy Immunol 2004; 26:161-70.
8. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses; risk factors, pathophysiologic basis and approach to management. Lancet Infect Dis 2007; 7:395-401.
9. Clark DA, Croitoru K. TH1/TH2,3 imbalance due to cytokine-producing NK-gammadelta T and NK-gammadelta T cells in murine pregnancy decidua in success or failure of pregnancy. Am J Reprod Immunol 2001; 45:257.
10. Krasnow J, Tollerud D, Naus G, et al. Endometrial Th2 cytokine expression throughout menstrual cycle and early pregnancy. Human Reproduction 1996; 11:1747-54.
11. Formy B. Immunologic response in pregnancy: its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol Metab Clin North Am 1995; 1:187-205.
12. Wilder R. Hormones, pregnancy, and autoimmune diseases. Ann NY Acad Sci 1998; 840:45-50.
13. Jamieson DJ, Theller RN, Rasmussen SA. Emerging infections and pregnancy. Emerg Infect Dis 2006; 12:1638-43.
14. Narita M, Yamada S, Kikuta H, et al. Reconstitution of humoral immunity during pregnancy. Am J Reprod Immunol 2000; 44:148-52.
15. Elenkov I, Wilder R, Bakalov V, et al. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 2001; 86:4933-8.
16. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunology Today 1999; 20:114-8.
17. Piccinni M, Giudizi M, Biagiotti R. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995; 155:128-33.
18. Gilmore W, Weiner L, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997; 158:446-51.
19. Bukharie H. Paradoxical response to anti-tuberculous drugs: resolution with corticosteroid therapy. Scand J Infect Dis 2000; 32:96-7.
20. Koguchi Y, Kawakami K. Cryptococcal infection and Th1-Th2 cytokine balance. Int Rev Immunol 2002; 21:423-38.
21. Decken K, Kohler G, Palmer-Lehmann K, et al. Interleukin-12 is essential for protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun 1998; 66:4994-5000.
22. Shelburne SA III, Darcourt J, White C Jr., et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:1045-52.
23. Silman A, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 1992; 35:152-5.
24. Confavreux C, Hutchinson M, Hours M, et al. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998; 339:285-91.
25. Amino N, Tada H, Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid 1999;9:705-13.
26. Benhaim RD, Davies TF. Increased risk of Graves' disease after pregnancy. Thyroid 2005; 15:1287-90.
27. Pajor A, Hintalan A, Bakos L, et al. Postpartum hemolytic uremic syndrome following placental abruption. Eur J Obstet Gynecol Reprod Biol 1993; 49:201-4.
28. Ehya H, Weitzner S. Postpartum dissecting aneurysm of coronary arteries in a patient with sarcoidosis. South Med J 1980; 73:87-8.
29. Hyman BN. Postpartum uveitis. Ann Ophthalmol 1976; 8:677-80.
30. Piliero PJ, Fish DG, Preston S, et al. Guillain-Barre syndrome associated with immune reconstitution. Clin Infect Dis 2003; 36:e111-4.
31. Vaduva C, de Seze J, Stojkovic T, et al. Severe Guillain-Barre syndrome and pregnancy: two cases with rapid improvement post-partum [in French]. Rev Neurol (Paris) 2006; 162:293-4.
32. Silvestre J, Albares MP, Ramon R, et al. Cutaneous intolerance to tattoos in a patient with human immunodeficiency virus: a manifetation of the immune restoration syndrome. Arch Dermatol 2001; 137:669-70.
33. Ford FD. Puerperal erythema nodosum after liver extract injections: treatment with prednisone. Br Med J 1960; 1:400-1.
34. Price P, Morahan G, Huang D, et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002; 16:2043-7.
35. Price P, Keane NM, Stone SF, Cheong KY, French MA. MHC haplotypes affect the expression of opportunistic infections in HIV patients. Hum Immunol 2001; 62:157-64.
36. Robinson A. The influence of childbearing upon pulmonary tuberculosis. Gynecol Brit Empire 1931; 38:338-66.
37. Brar H, Golde S, Egan J. Tuberculosis presenting as puerperal fever. Obstet Gynecol 1987; 70:488-90.
38. Brandstetter R, Murray H, Mellow E. Tuberculous meningitis in a puerperal woman. JAMA 1980; 244:2440.
39. D'Cruz I, Dandekar A. Tuberculous meningitis in pregnant and puerperal women. Obstet Gynecol 1968; 31:775-8.
40. Cheng VCC, Woo PCY, Lau SKP, et al. Peripartum tuberculosis as a form of immunorestitution disease. Eur J Clin Microbiol Infect Dis 2003; 22:313-7.
41. Maheswaran C, Neuwirth R. An unusual case of postpartum fever: acute hematogenous tuberculosis. Obstet Gynecol 1973; 41:765-9.
42. Myers J, Perlstein P, Light I, et al. Tuberculosis in pregnancy with fatal congenital infection. Pediatrics 1981; 67:89-94.
43. Ormerod P. Tuberculosis in pregnancy and the puerperium. Thorax 2001; 56:494-9.
44. Stavrou P, Sgouros S. Frontal lobe tuberuloma masquerading as postnatal depression. Br J Neurosurg 2007; 16:74.
45. Covelli H, Wilson R. Immunologic and medical considerations in tuberculin-sensitized pregnant patients. Am J Obstet Gynecol 1978; 132:256-9.
46. Wilson E, Thelin T, Dilts P. Tuberculosis complicated by pregnancy. Am J Obstet Gynecol 1972; 115:526-9.
47. Haas D. Mycobacterial disease. In: Mandell G, Bennett J, Dolin R, eds. Principles and practice of infectious disease. Philadelphia, PA: Church Livingston, 2000:2576-607.
48. Ellner JJ. The immune response in human tuberculosis: implications for tuberculosis. J Infect Dis 1997; 176:1351-9.
49. Nathan C, Kaplan G, Levis W, et al. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. N Engl J Med 1986; 315:6-15.
50. Kaplan G, Kiessling R, Teklemariam S, et al. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin. J Exp Med 1989; 169:893-907.
51. Gelber RH, Rea TH. Mycobacterium leprae: leprosy, Hansen's disease. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious disease. Philadelphia: Churchill Livingstone, 2007:2608-16.
52. Lyde C. Pregnancy in patients with Hansen disease. Arch Dermatol 1997; 133:623-7.
53. Kawakami K. Regulation by innate immune T lymphocytes in the host defense against pulmonary infection with Cryptococcus neoformans. Jpn J Infect Dis 2004; 57:137-45.
54. Vecchiarelli A, Retini C, Monari C, et al. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun 1996; 64:2846-9.
55. Chaka W, Hyderman R, Gangaidzo I, et al. Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis: no leukocytosis despite high interleukin-8 levels. J Infect Dis 1997; 176:1633-6.
56. Singh N, Lortholary O, Alexander BD, et al. Allograft loss in renal transplant recipients with C. neoformans associated immune reconstitution syndrome. Transplantation 2005; 80:1131-3.
57. Sirinavin S, Intusoma U, Tuntirungsee S. Mother-to-child transmission of cryptococcus neoforms. Pediatr Infect Dis J 2004; 23:278-9.
58. Ely EW, Peacock JE, Haponik EF, et al. Cryptococcal pneumonia complicating pregnancy. Medicine 1998; 77:153-67.
59. Einsiedel L, Gordon DL, Dyer JR. Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV seronegative woman. Clin Infect Dis 2004; 39:e78-82.
60. Annapureddy S, Masterson S, Huw D, et al. Post partum osteomyelitis due to Cryptococcus neoformans. Scand J Infect Dis 2007; 39:354-6.
61. LaGatta MA, Jordan C, Khan W, et al. Isolated pulmonary cryptococcosis in pregnancy. Obstet Gynecol 1998; 92:682-4.
62. Crum NF, Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature. Am J Med 2006; 119:993-7.
63. Spinello IM, Johnson RH, Baqi S. Coccidioidomycosis and pregnancy. Ann N Y Acad Sci 2007 [Epub ahead of print].
64. Wack EE, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during pregnancy: an analysis of ten cases among 47,120 pregnancies. Chest 1988; 94:376-9.
65. Hamer L, Castillo J. Coccidioidomycosis presenting as a massive pleural effusion in a postpartum woman. Indian J Chest Dis Allied Sci 2006;48:59-62.
66. Barbee R, Hicks M, Grosso D, et al. The maternal immune response to coccidioidomycosis. Chest 1991; 100:709-15.
67. Magee D, Cox R. Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis. Infect Immun 1995; 63:3514-9.
68. Magee D. Interleukin-12 regulation of host defenses against Coccidioides immitis. Infect Immun 1996; 64:3609-913.
69. Cox R, Magee D. Production of tumor necrosis factor alpha, interleukin-1α, and interleukin-6 during murine coccidioidomycosis. Infect Immun 1995; 63:4178-80.
70. Fierer J, Walls L, Eckmann L, et al. Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis. Infect Immun 1998; 66:4397-402.
71. Jimenez M, Walls L, Fierer J. High levels of interleukin-10 impair resistance to pulmonary coccidiodomycosis in mice in part through control of nitric oxide synthase 2 expression. Infect Immun 2006; 74:3387-95.
72. Arsura E, Bellinghausen P, Kilgore W, et al. Septic shock in coccidioidomycosis. Crit Care Med 1998; 26:62-5.
73. Drutz DJ, Huppert M, Sun SH, et al. Human sex hormones stimulate the growth and maturation of Coccidioides immitis. Infect Immun 1981; 32:897-907.
74. Daniel L, Salit IE. Blastomycosis during pregnancy. Can Med Assoc J 1984; 131:759-61.
75. Flecther H, Williams N, Nicholson A, et al. Sytemic phaeohyphomycosis in pregnancy and the puerperium. West Indian Med J 2000; 49:79.
76. Rutschmann OT, Negro F, Hirschel B, et al. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis 1998; 177:783-5.
77. Zylberberg H, Pialoux G, Carnot F, et al. Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy. Clin Infect Dis 1998; 27:1255-8.
78. Ragni MV, Bontempo FA. Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy. J Infect Dis 1999; 180:2027-9.
79. Drake A, Mijch A, Sasadeusz J. Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite laminvudine therapy as part of HAART. Clin Infect Dis 2004; 39:129-32.
80. Vento S, Cainelli F, Mirandola F, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 347:92-3.
81. Chen J, Chung J, Kao J, et al. Postpartum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother. J Gastroenterol Hepatol 2001; 16:705-8.
82. Soderstrom A, Norkrans G, Magnus L. Hepatitis B virus DNA during pregnancy and postpartum: aspects on vertical transmission. Scand J Infect Dis 2003; 35:814-9.
83. Sherman K, Shire N, Cernohous P, et al. Liver injury and changes in hepatitis C virus (HCV) RNA load assosicated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-confinfected patients: lopinavir-ritonavir versus nelfinavir. Clin Infect Dis 2005; 41:1186-95.
84. Chung R, Evans S, Yang Y, et al. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and not impaired by hepatitis C virus in co-infected subjects. AIDS 2002; 16:1915-23.
85. Ratnam CC, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006; 42:418-27.
86. Hollier LM, Scott LL, Murphree SS, et al. Postpartum endometritis caused by herpes simplex virus. Obstet Gynecol 1997; 89:836-8.
87. Remadi S, Finci V, Ismail A, Zacharie S, Vassilakos P. Herpetic endometritis after pregnancy. Pathol Res Pract 1995; 191:31-4.
88. Kumar A, Madden DL, Nankervis GA. Humoral and cell-mediated immune responses to herpesvirus antigens during pregnancy - a longitudinal study. J Clin Immunol 1984; 4:12-7.
89. Baker DA, Thomas J. The effect of prostaglandin E2 on the initial immune response to herpes simplex virus infection. Am J Obstet Gynecol 1985; 151:586-90.
90. Tanaka A, Hirota K, Takahashi K, et al. Suppression of cell mediated immunity to cytomegalovirus and tuberculin in pregnancy employing the leukocyte migration inhibition test. Microbiol Immunol 1983; 27:937-43.
91. Knowles WA, Gardner SD, Fox H. A comparison of cervical cytomegalovirus (CMV) excretion in gynaecological patients and post-partum women. Arch Virol 1982; 73:25-31.
92. Smith EM, Johnson SR, Jiang D, et al. The association between pregnancy and human papilloma virus prevalence. Cancer Detect Prev 1991; 15:397-402.
93. Bridgman E, Norwood V. Pulmonary tuberculosis in pregnancy. Bull Johns Hosp 1926; 38:83-111.